MorphoSys Enrolls First Patient in Phase 1b/2a Clinical Trial for MOR103 ... - CNNMoney.com (press release)

MorphoSys Enrolls First Patient in Phase 1b/2a Clinical Trial for MOR103 ... CNNMoney.com (press release) "We are very pleased that our Phase 1b/2a study in patients with rheumatoid arthritis has now started according to plan," commented Dr. Arndt Schottelius, ... and more »

CORRECTED-UPDATE 2-US approves Roche's Actemra arthritis drug - Reuters

SeniorJournal.com

CORRECTED-UPDATE 2-US approves Roche's Actemra arthritis drug Reuters VX) Actemra to treat rheumatoid arthritis, the company said on Friday. The drug, made by Roche's Genentech unit, is already approved for use in Europe and ... FDA Approves Rheumatoid-Arthritis DrugWall Street Journal Gluten-free vegan diet helps rheumatoid arthritisFood Consumer FDA Approves Actemra for Rheumatoid Arthritis TreatmentDrugWatch.com eMaxHealth -MyWayBusiness.com Business News -Washington Post all 246 news articles »

Flu vaccine doesn't work in arthritis patients treated with rituximab - Los Angeles Times (blog)

Flu vaccine doesn't work in arthritis patients treated with rituximab Los Angeles Times (blog) Other drugs used to treat arthritis have no effect on immunization, however. Rheumatoid arthritis, which affects more than 4.6 million people worldwide, ... and more »

Painful facts about arthritis - The Tribune

Painful facts about arthritis The Tribune It affects the knees or the shoulders, whereas rheumatoid arthritis can affect all areas of the body at the same time. It is extremely painful and is very ...